Emerging strategies on in silico drug development against COVID-19: challenges and opportunities

The importance of coronaviruses as human pathogen has been highlighted by the recent outbreak of SARS-CoV-2 leading to the search of suitable drugs to overcome respiratory infections caused by the virus. Due to the lack of specific drugs against coronavirus, the existing antiviral and antimalarial d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Manisha, Dhagat, Swasti, Eswari, J. Satya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438372/
https://www.ncbi.nlm.nih.gov/pubmed/32827661
http://dx.doi.org/10.1016/j.ejps.2020.105522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438372/
https://www.ncbi.nlm.nih.gov/pubmed/32827661
http://dx.doi.org/10.1016/j.ejps.2020.105522

Ejemplares similares